Evaluating glycolysis-associated biomarkers for radiotherapy sensitivity in head and neck squamous cancer - Top-Institutions - MDSpire

Evaluating glycolysis-associated biomarkers for radiotherapy sensitivity in head and neck squamous cancer

  • By

  • Bilan Xie

  • Hainan Yang

  • Chunyuan Lin

  • Jinzhi Lai

  • June 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

  • #4

    Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology

  • #5

    TUM Klinikum, Technical University of Munich
    TUM Klinikum, Technical University of Munich

    Munich, Bavaria

    Key Differentiators

    • Oncology

Original Source(s)

Evaluating glycolysis-associated biomarkers for radiotherapy sensitivity in head and neck squamous cancer

  • by Bilan Xie, Hainan Yang, Chunyuan Lin, Jinzhi Lai

  • June 29, 2026

Related Content

Correction: Follicular dendritic cell sarcoma associated with IgG4-related disease: a case report and literature review

Mixed adenoneuroendocrine carcinoma of the gallbladder: a case report and literature review

Pre-treatment CEMRI habitat radiomics and deep learning for noninvasive prediction of the VETC pattern in hepatocellular carcinoma: an exploratory radiogenomic analysis